Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression
Clinical trial NCT06005870 · RECRUITING
Trial details
- NCT number
- NCT06005870
- Sponsor
- Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-26
- Primary completion
- 2026-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.